Sign in
Active, not recruitingNo phase

COMMUNITY - the COVID-19 Immunity Study

Key facts

Who runs it
Danderyd Hospital
Where
Sweden2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
2,420 people enrolled
Started
15 Apr 2020
Expected to end
Apr 2027
Type of study
Observational, 2 groups
Treatments tested
  • Blood sampling
  • Mucosal sampling
  • PCR-test
Record updated
7 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Health care workers: Employment at Danderyd hospital at time of enrollment
  • COVID-19 patients: Admitted to Danderyd Hospital with confirmed SARS-CoV-2 infection at time of enrollment

Who cannot take part

  • No exclusion criteria

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The principal aim of the COMMUNITY study is to investigate immune responses following SARS-CoV-2 infection and/or vaccination in healthcare workers and hospitalized COVID-19 patients. The study aims to enroll a total of 5,000 healthcare workers and 500 COVID-19 patients. All participants are enrolled at Danderyd Hospital in Stockholm, Sweden. Participants will be followed every four months with blood and mucosal sampling in addition to demographic and clinical data provided by the participants and from national registries.

Read full original descriptionShow less

Primary outcome:

- Antibody responses in blood and mucosa following SARS-CoV-2 infection and/or vaccination

Secondary outcomes:

* Cellular immune responses following SARS-CoV-2 infection and/or vaccination * Antibody responses in blood and mucosa following following Influenza A/B infection and/or vaccination * Antibody responses in blood and mucosa following following RSV A/B infection

Blood and mucosal samples are collected every 4 months and at tighter intervals in sub studies. PCR testing is conducted upon symptoms of respiratory infections and with regular intervals regardless of symptomatology in sub studies. Participants provide detailed demographic and clinical data through a smart phone application-based questionnaire. Data on infection and vaccination history is collected from national registries

The 2 groups in the trial

  • The COMMUNITY cohort - healthcare workers

    5000 healthcare workers employed at Danderyd Hospital at time of enrollment

    Treatment: Blood sampling, Mucosal sampling, and PCR-test

  • The COMMUNITY cohort - COVID-19 patients

    500 patients admitted to Danderyd Hospital with confirmed SARS-CoV-2 infection

    Treatment: Blood sampling, Mucosal sampling, and PCR-test

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
7 October 2026